Evidence map›Paper›PMID 31234813›Full record

ArticleBMC cancer2019

Achieving a timely diagnosis for teenagers and young adults with cancer: the ACE "too young to get cancer?" study.

Rachel M Dommett, Hannah Pring, Jamie Cargill, Paul Beynon, Alison Cameron, Rachel Cox, Aoife Nechowska, Alison Wint, Michael C G Stevens

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Interventions to reduce the time to diagnosis of brain tumours.The Cochrane database of systematic reviews · 2020
    Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Rachel M DommettSouth West TYA Cancer Service, Bristol Haematology Oncology Centre, University Hospitals Bristol NHS Foundation Trust, Horfield Road, Bristol, BS2 8ED, UK.
Hannah PringSouth West TYA Cancer Service, Bristol Haematology Oncology Centre, University Hospitals Bristol NHS Foundation Trust, Horfield Road, Bristol, BS2 8ED, UK.
Jamie CargillSouth West TYA Cancer Service, Bristol Haematology Oncology Centre, University Hospitals Bristol NHS Foundation Trust, Horfield Road, Bristol, BS2 8ED, UK.
Paul BeynonSouth West TYA Cancer Service, Bristol Haematology Oncology Centre, University Hospitals Bristol NHS Foundation Trust, Horfield Road, Bristol, BS2 8ED, UK.
Alison CameronSouth West TYA Cancer Service, Bristol Haematology Oncology Centre, University Hospitals Bristol NHS Foundation Trust, Horfield Road, Bristol, BS2 8ED, UK.
Rachel CoxDepartment of Paediatric Haematology Oncology & BMT, Bristol Royal Hospital for Children, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
Aoife NechowskaSouth West TYA Cancer Service, Bristol Haematology Oncology Centre, University Hospitals Bristol NHS Foundation Trust, Horfield Road, Bristol, BS2 8ED, UK.
Alison WintMacmillan GP and NHS Bristol, North Somerset & South Gloucestershire CCG, Bristol, UK.
Michael C G StevensSouth West TYA Cancer Service, Bristol Haematology Oncology Centre, University Hospitals Bristol NHS Foundation Trust, Horfield Road, Bristol, BS2 8ED, UK. m.stevens@bristol.ac.uk.ORCID http://orcid.org/0000-0001-6466-551X
University Hospitals Bristol NHS Foundation Trust · GBBristol Clinical Commissioning Group · GB

Funding

Cancer Research UK ACE 20656
6 · The paper itself

Abstract

backgroundTime to diagnosis (TTD) concerns teenagers and young adults (TYA) with cancer and may affect outcome.

methodsHealthcare records from 105 TYA in a regional cancer service were assessed to document events from 1st symptom to treatment start. Detailed pathway construction was possible for 104 patients and allowed a multidisciplinary panel review of each pathway with assessment of good practice and lessons for the future.

results1st presentation was to primary care in 86, and 93% consulted in primary care before diagnosis. Routes to Diagnosis were 45% via urgent 2 Week Wait pathways and 38% as emergency referrals. Total Interval (time from 1st presentation to treatment start) was median 63 (range 1-559) days, varying within/between diagnoses. Patient interval (time from 1st symptom to 1st presentation) was longest for lymphoma, carcinoma and bone tumour (medians: 9, 12, 20 days). Overall, time in primary care was short (median 3, range 0-537 days) compared to secondary care (median 29, range 0-195 days) and longest for lymphoma, carcinoma, brain/CNS (medians: 10, 15, 16 days). Specialist Care interval (time from 1st specialist visit to treatment start) was longest for bone, brain/CNS, lymphoma, carcinoma (medians: 30, 33, 36, 48 days). 40% pathways were rated as showing good/best practice but 16% were less than satisfactory. Continued safety-netting/support was identified from primary care but analysis suggested opportunities for improvement in transition through secondary care.

conclusionsPrevious reports of prolonged TTD have focused on delay in referral from primary care but this study suggests that this might be reduced by optimising management in secondary care.

Indexed as

Early Detection of CancerTimeAdolescentDelivery of Health CareFemaleHumansMaleNeoplasmsNurse SpecialistsPrimary Health CareReferral and ConsultationSecondary Health CareTime-to-TreatmentYoung AdultPrimary careRoutes to diagnosisSecondary careTime to diagnosisTYA

Identifiers

PMID31234813
PMCPMC6591830
OpenAlexW2949583931

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.